Advertisement

Pulmonary Physiology and Rehabilitation Section

  • Pulmonary rehabilitation in ILD and PH: Expanding access beyond the center

    Pulmonary rehabilitation in ILD and PH: Expanding access beyond the center

    Pulmonary rehabilitation remains one of the most effective interventions available for chronic respiratory disease. The research has shown a need for structured long-term maintenance programs for patients with ILD and PH.


  • Closing the gap in pulmonary rehabilitation

    Closing the gap in pulmonary rehabilitation

    If pulmonary rehabilitation in the United States is going to meet the scale of need in coming years, it must grow consistently, equitably, and sustainably.


  • GOLDen handcuffs: Beyond spirometry in COPD

    GOLDen handcuffs: Beyond spirometry in COPD

    When it comes to diagnosing COPD, clinicians must look beyond spirometry and physiology to see a patient fully.


  • Extending exercise testing using telehealth monitoring in patients with ILD

    Extending exercise testing using telehealth monitoring in patients with ILD

    The COVID-19 pandemic revolutionized the use of monitoring equipment in general and oxygen saturation monitoring devices as pulse oximeters in specific. Home technology devices such as home spirometry, smart apps, and wearable sensors combined with patient-reported outcome measures are increasingly used to monitor disease progression and medication compliance in addition to routine physical activity. The increasing adoption…


  • Machine learning meets cardiopulmonary exercise testing

    Machine learning meets cardiopulmonary exercise testing

    Cardiopulmonary exercise testing (CPET) is a clinically useful modality to discriminate between cardiac, pulmonary, and musculoskeletal limitations to physical exertion. However, it is relatively underutilized due to the lack of local expertise necessary for accurate interpretation. Several studies have explored automation of CPET interpretation, the most notable of which utilized machine learning.1 Recently, Schwendinger et…


  • Use of 6-minute walk distance as a clinical trial outcome in interstitial lung disease

    Use of 6-minute walk distance as a clinical trial outcome in interstitial lung disease

    Pulmonary arterial hypertension (PH) and more recently interstitial lung disease (ILD) trials use the 6-minute walk test (6MWT) as a primary outcome due to its ability to conveniently capture a patient’s functional capacity and quality of life. However, interpreting the 6MWT in complex and diverse diseases, such as ILD, presents significant challenges. A recent article…